Full text is available at the source.
Abstract
High-level substitution of dendrogenin A (≥50%) impaired immune responses, while complete replacement with β-sitosterol enhanced T-cell responses.
- The reactivation of varicella-zoster virus leads to herpes zoster, which is particularly burdensome for immunocompromised individuals.
- Current herpes zoster vaccines have limitations, including age-dependent efficacy and manufacturing challenges.
- mRNA vaccines could offer a new approach for preventing herpes zoster, relying on lipid nanoparticles (LNPs) for effective delivery.
- Partial or complete replacement of cholesterol in LNPs with plant-derived β-sitosterol or dendrogenin A was tested.
- Complete replacement with β-sitosterol resulted in higher antigen-specific T-cell responses compared to traditional cholesterol-based LNPs.
- The immune response patterns induced by β-sitosterol-based LNPs were similar to those from cholesterol-based LNPs, lacking distinct inflammatory markers.
Simplified